Staff editor

Canada endorses groundbreaking gut-brain health claims for Chr. Hansen’s probiotic strain

This approval marks a significant leap forward in our understanding of holistic health and the intricate connection between our guts and our brains.

Probiotics and clinical practice

Francisco Guarner, from Centro Médico Teknon (Barcelona, Spain), talks about the recent update of the WGO’s Probiotics and prebiotics guidelines.

Gut microbiota is a key player for bone health in post-menopausal women

Bone resorption increases the risk of osteopenia and osteoporosis during and after menopause – learn about the importance of the gut microbiota to support healthy bones.

Alessio Fasano: ‘The future of personalized treatments and disease interception depends on microbiome research’

Alessio Fasano, pediatric gastroenterologist and researcher at Harvard Medical School, talks about the mechanistic link between gut microbiome and disease pathogenesis and the impact on the future clinical practice.

Nestlé’s innovation: elevating infant nutrition with HMOs and probiotic synergy for science-based early-life health

Nestlé, a global leader in nutrition and wellness, is taking a giant leap forward in early-life nutrition with its latest innovation – Sinergity.

Lallemand Health Solutions Acquires Dietary Pros Inc., US-Based Contract Manufacturer

The acquisition brings together two complementary forces, continue to respond to customer needs and help their growth with their respective strengths.

Gianluca Ianiro: ‘Here’s why engraftment is a key determinant of success in FMT’

Gianluca Ianiro, from Gemelli Hospital in Rome, discusses the key determinants of success of FMT in the treatment of C. Difficile infections and other conditions.

Expert’biome CDMO by Lallemand: leading microbiome forward

Lallemand launches Expert’Biome™ CDMO to support partners in their development of next-generation strains.

Persephone Biosciences and Ginkgo Bioworks Complete Reusable Bacteroides Anaerobic Engineering Toolkit

Persephone to utilize the Bacteroides technology for the rapid generation of therapeutics from its planned and ongoing biomarker studies, including the ARGONAUT study.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top